Mark A. Lyster

1.1k total citations · 1 hit paper
11 papers, 905 citations indexed

About

Mark A. Lyster is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, Mark A. Lyster has authored 11 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 5 papers in Molecular Biology and 3 papers in Spectroscopy. Recurrent topics in Mark A. Lyster's work include Oxidative Organic Chemistry Reactions (3 papers), Chemical Synthesis and Analysis (3 papers) and Analytical Chemistry and Chromatography (3 papers). Mark A. Lyster is often cited by papers focused on Oxidative Organic Chemistry Reactions (3 papers), Chemical Synthesis and Analysis (3 papers) and Analytical Chemistry and Chromatography (3 papers). Mark A. Lyster collaborates with scholars based in United States and Japan. Mark A. Lyster's co-authors include Michael E. Jung, Michael Jung, Manabu Node, John Lowe, Richard W. Brown, Bruce A. Pearlman, Paul M. Herrinton, Robert C. Gadwood, Michael R. Barbachyn and Mark T. Maloney and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Mark A. Lyster

11 papers receiving 863 citations

Hit Papers

Quantitative dealkylation... 1977 2026 1993 2009 1977 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark A. Lyster 683 276 91 70 69 11 905
L. M. WEINSTOCK 930 1.4× 348 1.3× 173 1.9× 71 1.0× 73 1.1× 55 1.2k
Yuichi Sugimoto 597 0.9× 194 0.7× 116 1.3× 70 1.0× 55 0.8× 42 787
Norihiro Ikemoto 488 0.7× 360 1.3× 79 0.9× 70 1.0× 50 0.7× 32 707
Takeshi Nakai 883 1.3× 171 0.6× 124 1.4× 49 0.7× 50 0.7× 58 997
Joseph Cs. Jászberényi 1.3k 1.9× 276 1.0× 112 1.2× 68 1.0× 67 1.0× 58 1.4k
Daniel Beaupère 663 1.0× 407 1.5× 139 1.5× 62 0.9× 79 1.1× 77 853
Tomáš Trnka 451 0.7× 386 1.4× 40 0.4× 49 0.7× 120 1.7× 73 762
M. Sletzinger 593 0.9× 266 1.0× 74 0.8× 128 1.8× 30 0.4× 41 802
F. GUIBE 908 1.3× 437 1.6× 148 1.6× 108 1.5× 64 0.9× 23 1.1k
Hideyoshi Miyake 688 1.0× 197 0.7× 83 0.9× 62 0.9× 46 0.7× 54 834

Countries citing papers authored by Mark A. Lyster

Since Specialization
Citations

This map shows the geographic impact of Mark A. Lyster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Lyster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Lyster more than expected).

Fields of papers citing papers by Mark A. Lyster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Lyster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Lyster. The network helps show where Mark A. Lyster may publish in the future.

Co-authorship network of co-authors of Mark A. Lyster

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Lyster. A scholar is included among the top collaborators of Mark A. Lyster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Lyster. Mark A. Lyster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Pearlman, Bruce A., Paul M. Herrinton, Robert C. Gadwood, et al.. (2003). The Synthesis of N-Aryl-5(S)-aminomethyl-2-oxazolidinone Antibacterials and Derivatives in One Step from Aryl Carbamates. Organic Process Research & Development. 7(4). 533–546. 69 indexed citations
2.
Dobrowolski, Paul J., et al.. (1997). Production Scale Synthesis of the Non-Nucleoside Reverse Transcriptase Inhibitor Atevirdine Mesylate (U-87,201E). Organic Process Research & Development. 1(2). 106–116. 13 indexed citations
3.
Bergren, Michael S., P. A. MEULMAN, Ronald W. Sarver, et al.. (1996). Solid Phases of Delavirdine Mesylate. Journal of Pharmaceutical Sciences. 85(8). 834–841. 9 indexed citations
4.
Farley, Kathleen A., Gregory S. Walker, Russell H. Robins, et al.. (1996). Spectroscopic studies of delavirdine mesylate (U‐90,152T) a bis(heteroaryl)piperazine (BHAP) HIV reverse transcriptase inhibitor. Journal of Heterocyclic Chemistry. 33(2). 493–496. 2 indexed citations
6.
Jung, Michael E., et al.. (1982). Regiospecific synthesis of bicyclic 6-alkoxy-2-pyrones and their use in the production of tetracyclic intermediates for 11-deoxyanthracycline synthesis. The Journal of Organic Chemistry. 47(6). 1150–1152. 30 indexed citations
8.
Jung, Michael E., et al.. (1978). Direct synthesis of dibenzocyclooctadienes via double ortho Friedel-Crafts alkylation by the use of aldehyde-trimethylsilyl iodide adducts. The Journal of Organic Chemistry. 43(19). 3698–3701. 55 indexed citations
9.
Jung, Michael E. & Mark A. Lyster. (1978). Conversion of alkyl carbamates into amines via treatment with trimethylsilyl iodide. Journal of the Chemical Society Chemical Communications. 315–315. 95 indexed citations
10.
Jung, Michael & Mark A. Lyster. (1977). Quantitative dealkylation of alkyl esters via treatment with trimethylsilyl iodide. A new method for ester hydrolysis. Journal of the American Chemical Society. 99(3). 968–969. 219 indexed citations
11.
Jung, Michael E. & Mark A. Lyster. (1977). Quantitative dealkylation of alkyl ethers via treatment with trimethylsilyl iodide. A new method for ether hydrolysis. The Journal of Organic Chemistry. 42(23). 3761–3764. 369 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026